1. Home
  2. ACXP vs RBNE Comparison

ACXP vs RBNE Comparison

Compare ACXP & RBNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • RBNE
  • Stock Information
  • Founded
  • ACXP 2017
  • RBNE 2024
  • Country
  • ACXP United States
  • RBNE Cyprus
  • Employees
  • ACXP N/A
  • RBNE N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • RBNE Marine Transportation
  • Sector
  • ACXP Health Care
  • RBNE Consumer Discretionary
  • Exchange
  • ACXP Nasdaq
  • RBNE Nasdaq
  • Market Cap
  • ACXP 8.4M
  • RBNE 7.3M
  • IPO Year
  • ACXP 2021
  • RBNE N/A
  • Fundamental
  • Price
  • ACXP $0.43
  • RBNE $3.35
  • Analyst Decision
  • ACXP Strong Buy
  • RBNE
  • Analyst Count
  • ACXP 2
  • RBNE 0
  • Target Price
  • ACXP $10.00
  • RBNE N/A
  • AVG Volume (30 Days)
  • ACXP 18.4M
  • RBNE 9.7M
  • Earning Date
  • ACXP 08-08-2025
  • RBNE 08-21-2025
  • Dividend Yield
  • ACXP N/A
  • RBNE N/A
  • EPS Growth
  • ACXP N/A
  • RBNE N/A
  • EPS
  • ACXP N/A
  • RBNE N/A
  • Revenue
  • ACXP N/A
  • RBNE N/A
  • Revenue This Year
  • ACXP N/A
  • RBNE N/A
  • Revenue Next Year
  • ACXP N/A
  • RBNE N/A
  • P/E Ratio
  • ACXP N/A
  • RBNE N/A
  • Revenue Growth
  • ACXP N/A
  • RBNE N/A
  • 52 Week Low
  • ACXP $0.30
  • RBNE $2.38
  • 52 Week High
  • ACXP $3.33
  • RBNE $20.57
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 47.99
  • RBNE N/A
  • Support Level
  • ACXP $0.52
  • RBNE N/A
  • Resistance Level
  • ACXP $0.63
  • RBNE N/A
  • Average True Range (ATR)
  • ACXP 0.09
  • RBNE 0.00
  • MACD
  • ACXP 0.00
  • RBNE 0.00
  • Stochastic Oscillator
  • ACXP 17.33
  • RBNE 0.00

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About RBNE Robin Energy Ltd. Common Stock

Robin Energy Ltd operates a tanker vessel that engages in the transportation of refined petroleum products using its Handysize product tanker.

Share on Social Networks: